NEWS & PERSPECTIVES

Psychedelics News

Curated updates on microdosing, research, policy, and community.

The latest

2026-04-06 • The Microdose (Berkeley)

Carne de Dios

An excerpt of a novel by the Mexican writer Homero Aridjis

2026-04-06 • Seeing What Is There (Substack)

Books the New York Times Covers & Books They Don't

A lawsuit over a another overhyped psychedelic-trip book demonstrates again how well and truly broken publishing is

2026-04-06 • DoubleBlind Magazine

What It Takes to Gather Now in the Psychedelic Movement

Plus, growing entheogens at home, LSD blotters, and scientology. [...] Read More... The post What It Takes to Gather Now in the Psychedelic Movement appeared first on DoubleBlind Mag.

2026-04-06 • OPEN Foundation

Attachment Meets Psychedelics: What the Research Suggests So Far

A new critical literature review by Cassidy, Davis, and Rao (2026), published in Psychedelics, is the first comprehensive examination of the intersection of attachment theory and psychedelic research. At its core, it ...

2026-04-05 • The Psychedelic Blog (Substack)

Inside the At-Home Ketamine Model (And What Happens When It Goes Wrong)

This week’s Sunday Insider: what I saw going through one of the most popular at-home ketamine therapy models.

2026-04-04 • Chemical Collective

Psychedelics and Coercion

While certain substances like scopolamine and classical psychedelics induce a state of suggestibility that has been historically exploited by criminals for coercion and weaponised by the CIA, this same neurological op...

2026-04-03 • Psychedelic Health

Another Big Pharma Bet on Psychedelics: Otsuka Buys $1.2 Billion MDMA Analog Program

Japanese pharma company Otsuka Pharmaceutical announced its acquisition of Transcend Therapeutics, Inc., The post Another Big Pharma Bet on Psychedelics: Otsuka Buys $1.2 Billion MDMA Analog Program appeared first on ...

2026-04-03 • Psychedelics Today

Ketamine-Assisted Couple Therapy Training by Enamory

This educational workshop is the first step toward certification in the Enamory model of Ketamine-Assisted Couple Therapy (couples’ KAP). Learn how to conduct an assessment and build a case formulation for couples’ KA...

2026-04-03 • The Psychedelic Blog (Substack)

The Personality Shift That Happens First

Welcome to the Psychedelic Blog. I write about the impact of Psychedelics on Grieving, Relationships, Culture & Death.

2026-04-03 • DoubleBlind Magazine

Psychedelic Reform Without Home Grow Is Still Prohibition

If you can’t grow your own medicine, pharma corporations and the Drug War still win...at our expense. [...] Read More... The post Psychedelic Reform Without Home Grow Is Still Prohibition appeared first on DoubleBlind...

2026-04-01 • DoubleBlind Magazine

Your Passport to the World’s Most Psychedelic Gatherings

A curated trip through music, art, and radical connection worldwide. [...] Read More... The post Your Passport to the World’s Most Psychedelic Gatherings appeared first on DoubleBlind Mag.

2026-04-01 • Zendo Project

Zendo Lab Update: March 2026

Lately, I’ve been reflecting on what it means to spend almost twenty years… The post Zendo Lab Update: March 2026 appeared first on Zendo Project.

2026-04-01 • Chemical Collective

Why is the Message Not to Take Life So Seriously Common on Psychedelics?

Psychedelics can enhance humour and laughter, which may help people bond socially, gain new perspectives, loosen attachment to the ego, and potentially access deeper insights by not taking life – or the self – too ser...

2026-03-31 • Australian Psychedelic Society

Meet Yopo, Ayahuasca's Grandfather: the Sacred Plant No One's Heard Of.

Yopo, the oldest of them all, the grandfather of the entire lineage, the medicine with the longest unbroken ceremonial record in the world, has been passed over almost entirely. There is no clinical trial. There are...

2026-03-31 • PsyMed Ventures

How Gilgamesh Landed a $1.2B AbbVie Deal in Psychedelics

Jonathan Sporn (CEO + Founder of Gilgamesh Pharma) joins for a deep dive into next-gen psychedelic medicines, why duration matters for real-world clinical use, and more.